Skip to main content
Article thumbnail
Location of Repository

Adalimumab effectively reduces the rate of anterior uveitis flares in patients with active ankylosing spondylitis: results of a prospective open-label study

By M Rudwaleit, E Rødevand, P Holck, J Vanhoof, M Kron, S Kary and H Kupper
Topics: Clinical and Epidemiological Research
Publisher: BMJ Publishing Group
OAI identifier: oai:pubmedcentral.nih.gov:2663712
Provided by: PubMed Central
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • http://www.pubmedcentral.nih.g... (external link)
  • Suggested articles

    Citations

    1. (2001). Ankylosing spondylitis assessment group preliminary definition of short-term improvement in ankylosing spondylitis. Arthritis Rheum
    2. Anti-TNF therapies in the management of acute and chronic uveitis.
    3. Anti-TNF therapy for eye involvement in spondyloarthropathy. Clin Exp Rheumatol 2002;20(Suppl 28):S143–5.
    4. Anti-tumor necrosis factor-a therapy with infliximab as an alternative to corticosteroids in the treatment of human leukocyte antigen B27-associated acute anterior uveitis.
    5. (2006). ASAS Working Group. First update of the international ASAS consensus statement for the use of anti-TNF agents in patients with ankylosing spondylitis. Ann Rheum Dis
    6. (2006). Bre ´zin AP. Severe uveitis in an HLA-B27-positive patient with ankylosing spondylitis. Nat Clin Pract Rheumatol
    7. (2005). Decreased incidence of anterior uveitisi n patients with ankylosing spondylitis treated with the anti-tumor necrosis factor agents infliximab and etanercept. Arthritis Rheum
    8. (2004). Development and preselection of criteria for short term improvement after anti-TNFa treatment. Ann Rheum Dis
    9. Differential effectiveness of etanercept and infliximab in the treatment of ocular inflammation.
    10. (2001). Differential efficacy of tumor necrosis factor inhibition in the management of inflammatory eye disease and associated rheumatic disease. Arthritis Rheum
    11. Do tumor necrosis factor inhibitors cause uveitis? A registry-based study.
    12. Does etanercept induce uveitis?
    13. Efficacy of etanercept in preventing relapse of uveitis controlled by methotrexate.
    14. (2006). Efficacy of tumour necrosis factors blockers in reducing uveitis flares in spondyloarthropathy: a retrospective study. Ann Rheum Dis
    15. (2005). et al.A randomized, placebo-controlled, double-masked clinical trial of etanercept for the treatment of uveitis associated with juvenile idiopathic arthritis. Arthritis Rheum
    16. (1994). Evaluation of diagnostic criteria for ankylosing spondylitis: a proposal for modification of the New York criteria. Arthritis Rheum 1984;27:361–8. Extended report 700 Ann Rheum Dis 2009;68:696–701. doi:10.1136/ard.2008.09258526.
    17. Favorable response to high-dose infliximab for refractory childhood uveitis.
    18. (2007). Infliximab and etanercept in the treatment of chronic uveitis associated with refractory juvenile idiopathic arthritis. Ann Rheum Dis
    19. Infliximab therapy for the treatment of refractory ocular inflammatory disease.
    20. (2003). International ASAS consensus statement for the use of anti-tumour necrosis factor agents in patients with ankylosing spondylitis. Ann Rheum Dis
    21. Ocular inflammatory disease in patients with RA taking etanercept: is discontinuation of etanercept necessary?
    22. Ophthalmic findings and frequency of extraocular manifestations in patients with HLA-B27 uveitis: a study of 175 cases.
    23. (2001). Ophthalmologic manifestations of rheumatic diseases. Semin Arthritis Rheum
    24. (2008). Predictors of major clinical responses (BASDAI50, ASAS40, ASAS partial remission) in 1,250 patients treated with adalimumab (HUMIRA) for active ankylosing spondylitis. Ann Rheum Dis
    25. Prevalence of the spondylarthritides in patients with uveitis.
    26. (2007). Recurrent new-onset uveitis in a patient with rheumatoid arthritis during anti-TNFa treatment. Reumatismo
    27. (2003). Recurrent uveitis in a patient with juvenile spondyloarthropathy associated with tumour necrosis factor a inhibitors. Ann Rheum Dis
    28. (2003). Sarcoid-related uveitis occurring during etanercept therapy. Clin Exp Rheumatol
    29. (2002). Staging of patients with ankylosing spondylitis: a preliminary proposal. Ann Rheum Dis
    30. Standardization of Uveitis Nomenclature (SUN) Working Group. Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop.
    31. Sulfasalazine in the prevention of anterior uveitis associated with ankylosing spondylitis.
    32. (2006). Tumour necrosis factor a inhibitors in the treatment of childhood uveitis. Rheumatology
    33. Undiagnosed spondyloarthropathy in patients presenting with anterior uveitis.
    34. Uveitis and tumour necrosis factor blockade in ankylosing spondylitis. Ann Rheum Dis 2008;67:729–30. Extended report Ann Rheum Dis 2009;68:696–701.

    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.